← Back to Search

Behavioural Intervention

Virtual Reality Rehabilitation for Hemianopia in Children (HH-IVR Trial)

N/A
Waitlist Available
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 8 years old
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 months
Awards & highlights

HH-IVR Trial Summary

This trial seeks to investigate the use of a home-based stimulation visual rehabilitation program using immerse-virtual reality in children aged 4-10 years old with a diagnosis of hemianopia.

Who is the study for?
This trial is for children aged over 8 with hemianopia, a type of visual field loss, due to a brain tumor or its treatment. They must have decent vision (BCVA > 20/200), be able to follow instructions, and have home Wi-Fi. Kids with vertigo, previous vision rehab, certain eye diseases or drug use can't join.Check my eligibility
What is being tested?
The study tests a home-based visual rehabilitation program using immersive virtual reality (IVR) designed for kids with hemianopia. It aims to see if this technology helps improve their ability to see and interact with the world around them.See study design
What are the potential side effects?
Potential side effects may include discomfort from wearing VR equipment, eye strain from prolonged screen time, and possibly dizziness or disorientation related to VR use.

HH-IVR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are older than 8 years.

HH-IVR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility and effectiveness of a home based audiovisual stimuaton in immersive virtual-reality to restore visual perception in children with brain tumour associated hemianopia.
Secondary outcome measures
Change in Field of vision
Change in Quality of life
Change in Reading speed
+1 more

HH-IVR Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionalExperimental Treatment1 Intervention
Immersive virtual-reality stimulation (IVR): 1 session of 3 blocks of 15 trials of 20 seconds each. Rest time is 1-2 minute(s) between blocks. 1 session lasts 19 minutes.1 session every 2 days for 4 weeks (15 sessions total).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Immersive Virtual-Reality Stimulation
2022
N/A
~10

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
686 Previous Clinical Trials
6,944,783 Total Patients Enrolled
University Health Network, TorontoOTHER
1,468 Previous Clinical Trials
484,509 Total Patients Enrolled

Media Library

Immersive Virtual-Reality Stimulation (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05065268 — N/A
Hemianopia Research Study Groups: Interventional
Immersive Virtual-Reality Stimulation (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05065268 — N/A
Hemianopia Clinical Trial 2023: Immersive Virtual-Reality Stimulation Highlights & Side Effects. Trial Name: NCT05065268 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the requirements to partake in this research?

"This clinical trial seeks 10 individuals, aged 8 to 21 years old, who suffer from homonymous hemianopsia. Participants must have a minimum visual acuity of 20/200, an interpupillary distance greater than or equal to 56 mm and the ability to comprehend auditory and visual stimuli as well as training instructions. Furthermore, all participants should have access to Wi-Fi in their homes."

Answered by AI

Is recruitment for this medical research still open?

"Data on clinicaltrials.gov reveals that this experiment is no longer looking for participants, with the last update being made on October 20th 2021 - shortly after it was posted in November 1st of 2021. Luckily, there are still 463 trials actively searching for subjects at present."

Answered by AI

What is the primary purpose of this trial?

"For a period of 7 months, the objective of this research is to gauge feasibility. Secondary outcomes will measure changes in contrast sensitivity (FACT), visual acuity and quality-of-life scores using various standard tests administered by ophthalmologists over two 4 week intervals."

Answered by AI

Is eligibility for this experiment limited to individuals under a certain age?

"This evaluation is open to participants aged between 8 and 21."

Answered by AI
~3 spots leftby Apr 2025